The US Food and Drug Authority has FDA closed a factory in Baltimore, Maryland, where raw materials for Janssen’s vaccine were made. A report shows that there were problems with, among other things, hygiene in the building and that poorly trained staff were working.
–
It can take months for all problems to be resolved at the factory, according to the FDA. Johnson & Johnson says it will address criticisms “promptly and completely” and work around the clock to develop and activate manufacturing capabilities.
–
Belgium expects 62,400 new vaccines from Johnson & Johnson next week. It is not yet clear whether future deliveries will be affected by the production shutdown at the US plant.
–
